Home › NCT02438904

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

Recruiting

Who can join

All ages · All sexes

Full eligibility criteria

Inclusion Criteria:

1\) Patients who have poor or no graft function post stem cell transplantation.

Exclusion Criteria:

N/A

About the study

Objectives:

Primary Objective

To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

What is being tested

CD34 Positive Stem Cell Infusion (biological)
Miltenyi device (device)

Sponsor: M.D. Anderson Cancer Center · Participants: 200 · Started: May 6, 2015

Contact the study team

Elizabeth Shpall, MD · Phone: 713-745-2161

Official record on ClinicalTrials.gov — NCT02438904

Locations in the U.S.

Texas

University of Texas MD Anderson Cancer Center, Houston

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.